FLUORESCENT PEPTIDE-HORMONES - DEVELOPMENT OF HIGH-AFFINITY VASOPRESSIN ANALOGS

被引:13
作者
GUILLON, G
BARBEAU, D
NEUGEBAUER, W
GUAY, S
BILODEAU, L
BALESTRE, MN
GALLOPAYET, N
ESCHER, E
机构
[1] UNIV SHERBROOKE,FAC MED,DEPT PHARMACOL,SHERBROOKE J1H 5N4,QUEBEC,CANADA
[2] CNRS,INSERM,CTR PHARMACOL ENDOCRINOL,F-34094 MONTPELLIER,FRANCE
[3] UNIV SHERBROOKE,FAC MED,DEPT MED,SHERBROOKE J1H 5N4,QUEBEC,CANADA
基金
英国医学研究理事会;
关键词
VASOPRESSIN; VASOPRESSIN ANALOGS; FLUORESCENT REPORTER GROUPS;
D O I
10.1016/0196-9781(92)90133-N
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Highly potent and specific peptide hormone analogues with fluorescent reporter groups are current research goals. Until now, however, only moderately potent analogues have been described. We report here several types of vasopressin (VP) analogues with different fluorophores attached to the peptide. In a first series, fluorophores were attached to the free epsilon-amino function of [des-amino1-lysine8]VP (dLVP), producing agonistic analogues. In a second series, reporter groups were added to the N-terminal of open-chain antagonist structures. The biological activities of these analogues were assessed by two different sets of experiments: 1) The measurement of their binding affinities towards the V1a-vasopressin receptor subtype from WRK1 cells or rat liver membrane preparations; 2) Their ability to stimulate the phospholipase C activity in WRK1 cells. As expected, a simple acylation of fluorophores to dLVP resulted in a considerable loss of affinity. If, however, the Lys8 side chain was extended through double Schiff-base formation with glutaraldehyde-ethylenediamine followed by reduction to an aminoalkyl aminoalkylamine, single fluorophores could be added without loss of affinity compared to VP. The open-chain analogues, on the other hand, while displaying weak affinity, nevertheless exhibited pure antagonistic behavior.
引用
收藏
页码:7 / 11
页数:5
相关论文
共 17 条
[1]   PREPARATION AND BIOLOGICAL-ACTIVITIES OF POTENTIAL VASOPRESSIN PHOTOAFFINITY LABELS [J].
BARBEAU, D ;
GUAY, S ;
NEUGEBAUER, W ;
ESCHER, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (01) :151-157
[2]  
BUKU A, 1990, INT J PEPT PROT RES, V35, P128
[3]   FLUORESCENT, PHOTOAFFINITY, AND BIOTINYL ANALOGS OF OXYTOCIN [J].
BUKU, A ;
YAMIN, N ;
GAZIS, D .
PEPTIDES, 1988, 9 (04) :783-786
[4]   HUMAN PLACENTAL LHRH RECEPTOR - AGONIST AND ANTAGONIST LABELING PRODUCES DIFFERENCES IN THE SIZE OF THE NON-DENATURED, SOLUBILIZED RECEPTOR [J].
ESCHER, E ;
MACKIEWICZ, Z ;
LAGACE, G ;
LEHOUX, JG ;
GALLOPAYET, N ;
BELLABARBA, D ;
BELISLE, S .
JOURNAL OF RECEPTOR RESEARCH, 1988, 8 (1-4) :391-405
[5]   IODINATED PHOTOREACTIVE VASOPRESSIN ANTAGONISTS - LABELING OF HEPATIC VASOPRESSIN RECEPTOR SUBUNITS [J].
FAHRENHOLZ, F ;
KOJRO, E ;
MULLER, M ;
BOER, R ;
LOHR, R ;
GRZONKA, Z .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 161 (02) :321-328
[6]  
GUILLEMETTE G, 1986, MOL PHARMACOL, V30, P544
[7]   INFLUENCE OF BACTERIAL TOXINS AND FORSKOLIN UPON VASOPRESSIN-INDUCED INOSITOL PHOSPHATE ACCUMULATION IN WRK-1 CELLS [J].
GUILLON, G ;
BALESTRE, MN ;
LOMBARD, C ;
RASSENDREN, F ;
KIRK, CJ .
BIOCHEMICAL JOURNAL, 1989, 260 (03) :665-672
[8]   CHARACTERIZATION OF SPECIFIC V1A VASOPRESSIN-BINDING SITES ON A RAT MAMMARY-TUMOR-CELL LINE [J].
GUILLON, G ;
KIRK, CJ ;
BALESTRE, MN .
BIOCHEMICAL JOURNAL, 1986, 240 (01) :189-196
[9]   MECHANISMS OF PHOSPHOLIPASE-C ACTIVATION - A COMPARISON WITH THE ADENYLATE-CYCLASE SYSTEM [J].
GUILLON, G ;
BALESTRE, MN ;
MOUILLAC, B ;
BERRADA, R ;
KIRK, CJ .
BIOCHIMIE, 1987, 69 (04) :351-363
[10]   ACTIVATION OF MEMBRANE PHOSPHOLIPASE-C BY VASOPRESSIN - A REQUIREMENT FOR GUANYL NUCLEOTIDES [J].
GUILLON, G ;
BALESTRE, MN ;
MOUILLAC, B ;
DEVILLIERS, G .
FEBS LETTERS, 1986, 196 (01) :155-159